Approval · Notice of Compliance 7822 · 2006
VANTAS: Notice of Compliance 7822
Issued March 10, 2006
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7822
- Date
- March 10, 2006
- Company
- Paladin Labs Inc
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Luteinizing hormone-releasing hormone (lhrh) analog
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VANTAS | 02278383 | Cancelled Post Market |
Medicinal ingredients
- HISTRELIN ACETATE 50 MG per IMP